FEATURES OF HUMORAL IMMUNITY IN PATIENTS CHRONIC OBSTRUCTIVE LUNG DISEASE IN COVID-19 SURVIVORS

Abstract

Questions related to the topic of the joint course of the new coronavirus infection COVID-19 and chronic obstructive pulmonary disease (COPD) are currently very relevant. This is due to the similarity of clinical manifestations, the complexity of diagnosis. COPD patients with comorbid diseases infected with SARS-CoV-2 represent a particularly vulnerable group of people with a complicated course and often an unfavorable outcome of the disease. In light of the above, the study of laboratory indicatorsfeatures of the course and risk factors for cardiovascular complications, the development of effective methods for the treatment and rehabilitation of patients with COPD in combination with the metabolic syndrome against the background of COVID-19 remains an urgent problem. A new effective approach has been developed for the early diagnosis of chronic obstructive pulmonary disease (COPD) based on the clinical and immunological characteristics of the disease. The study included 46 patients with COPD who were in the departments of allergology and pulmonology of the Samarkand city medical association in 2022-2023. Changes in the profile of interleukins in blood serum depending on the stage and sex in COPD are described in detail.